Zurück
1 Mio Aktien gehandelt. Sollte morgen in der 1 Handelsstunde weiterlaufen
Top-News
BiopharmX vs Neothetics vs Galena
Beiträge: 57
Zugriffe: 26.792 / Heute: 2
Zugriffe: 26.792 / Heute: 2
|
|
| ||||||||||||||||||||
Werbung
Entdecke die beliebtesten ETFs von Amundi
Lyxor Net Zero 2050 S&P World Climate PAB (DR) UCITS ETF Acc
Perf. 12M: +206,18%
Amundi Nasdaq-100 Daily (2x) Leveraged UCITS ETF - Acc
Perf. 12M: +72,94%
Amundi ETF Leveraged MSCI USA Daily UCITS ETF - EUR (C/D)
Perf. 12M: +55,51%
Amundi MSCI India II UCITS ETF - EUR Acc
Perf. 12M: +38,10%
Amundi Japan TOPIX II UCITS ETF - EUR Hedeged Dist
Perf. 12M: +37,57%
Schaut auf die Performance der letzten Tage und letzte News, Power on!!!
für eine Reaktion.... wurde alles besprochen.... jetzt ist warten angesagt... bin schon gut positioniert aber stehe auch nochmal tiefer bereit....
Dir die Frage nicht beantworten....sonst ist hier z.Z. ja auch nicht viel los, denke das niemand hier die Frage beantworten kann...
interessieren
„The special meeting of stockholders of Neothetics will be held on January 5, 2018 at 8:00 a.m., local time, at the offices of DLA Piper LLP (US) located at 4365 Executive Drive, Suite 1100, San Diego, CA 92121“
http://www.conferencecalltranscripts.org/no/summary2/?id=4400092
Denkt dran, wo der Kurs nach Closing stehen sollte: „Neothetics will issue and sell in a private placement transaction, or the Financing, $20 million of Neothetics common stock to existing Evofem Investors at a price per share equal to $2.0677“
„The special meeting of stockholders of Neothetics will be held on January 5, 2018 at 8:00 a.m., local time, at the offices of DLA Piper LLP (US) located at 4365 Executive Drive, Suite 1100, San Diego, CA 92121“
www.conferencecalltranscripts.org/no/summary2/?id=4400092
Denkt dran, wo der Kurs nach Closing stehen sollte: „Neothetics will issue and sell in a private placement transaction, or the Financing, $20 million of Neothetics common stock to existing Evofem Investors at a price per share equal to $2.0677“
www.conferencecalltranscripts.org/no/summary2/?id=4400092
Denkt dran, wo der Kurs nach Closing stehen sollte: „Neothetics will issue and sell in a private placement transaction, or the Financing, $20 million of Neothetics common stock to existing Evofem Investors at a price per share equal to $2.0677“
Hat jemand einenLink oder Infos zu dieser Explosion? Was sind hier die Kurstreiber? Danke
www.reddit.com/r/RobinHoodPennyStocks/...ch_rumors_and_mores/
1.) Annual ROTH Conference Date: March 11st 2018
The ROTH Conference is basically a dick showing contest. 550 companies come from around the world and showcase their company and products. This should be great exposure for BPMX and if I am a betting man after the conference we will see higher volume and maybe a price jump.
2.) BPMX announces their earnings and possible FDA approval Date: March 22nd 2018
3.) Completion of BPX-01 and BPX-04, clinical trials Date: June 2018
The ROTH Conference is basically a dick showing contest. 550 companies come from around the world and showcase their company and products. This should be great exposure for BPMX and if I am a betting man after the conference we will see higher volume and maybe a price jump.
2.) BPMX announces their earnings and possible FDA approval Date: March 22nd 2018
3.) Completion of BPX-01 and BPX-04, clinical trials Date: June 2018
www.sec.gov/Archives/edgar/data/885725/...2018creditagree.htm
www.prnewswire.com/news-releases/...tock-split-300831591.html
www.rttnews.com/3009709/...s-primary-secondary-endpoints.aspx
- vorbörslich aktuell bei 0,61$ (-15%)
- geringe Cashreichweite
biopharmx.investorroom.com/...X-04-for-Papulopustular-Rosacea
biopharmx.investorroom.com/...-Quarter-2020-Financial-Results
|
Neueste Beiträge aus dem Timber Pharmaceuticals Inc Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
2 | 52 | Biopharmx - auf der Watchlist für 2016 | Temesta | Banaza | 27.11.23 08:02 | |
| 56 | BiopharmX vs Neothetics vs Galena | Temesta | logall | 24.04.21 23:13 |
